scispace - formally typeset
D

Deborah Castelletti

Researcher at Novartis

Publications -  11
Citations -  735

Deborah Castelletti is an academic researcher from Novartis. The author has contributed to research in topics: Medulloblastoma & Cancer. The author has an hindex of 8, co-authored 10 publications receiving 578 citations. Previous affiliations of Deborah Castelletti include Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening

E. Robert McDonald, +99 more
- 27 Jul 2017 - 
TL;DR: A large-scale RNAi screen is conducted in which viability effects of mRNA knockdown were assessed for 7,837 genes using an average of 20 shRNAs per gene in 398 cancer cell lines, outlining the classes of cancer dependency genes and their relationships to genetic, expression, and lineage features.
Journal ArticleDOI

Quassinoids: From traditional drugs to new cancer therapeutics

TL;DR: Quassinoids are a group of compounds extracted from plants of the Simaroubaceae family, which have been used for many years in folk medicine as mentioned in this paper and have a wide range of inhibitory effects.
Journal ArticleDOI

NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma

TL;DR: It is demonstrated that MB cells bear abnormal levels of distinct NOTCH ligands, and a mechanistic link between the oncogene MYC and NOTCH pathway in MB is described for the first time, by identifying JAG2 as MYC target, and by showing thatMB cells acquire induced expression of J AG2 through MYC-induced transcriptional activation.